Skip to content
10-Q

Quarterly Report

TONGLI PHARMACEUTICALS (USA), INC.

0001144204-12-062054

← back to feed
Filed
Nov 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2012 · Nov 8, 2012 14.85M sh
Stockholders Equity Q2 2012 · Sep 30, 2012 $19.08M
Stockholders Equity Q2 2012 · Mar 31, 2012 $18.34M
Current Liabilities Q2 2012 · Sep 30, 2012 $719.29K
Current Liabilities Q2 2012 · Mar 31, 2012 $1.5M
Current Assets Q2 2012 · Sep 30, 2012 $8.39M
Current Assets Q2 2012 · Mar 31, 2012 $9.14M
Total Assets Q2 2012 · Sep 30, 2012 $19.8M
Total Assets Q2 2012 · Mar 31, 2012 $19.84M
Operating Cash Flow Q2 2012 · Sep 30, 2011 −$1.46M
Sga Expense Q2 2012 · Sep 30, 2011 $918.11K
Sga Expense Q2 2012 · Sep 30, 2011 $1.14M
Net Income Q2 2012 · Sep 30, 2011 $337.36K
Net Income Q2 2012 · Sep 30, 2011 $1.94M
Operating Income Q2 2012 · Sep 30, 2011 $751.37K
Operating Income Q2 2012 · Sep 30, 2011 $2.95M
Gross Profit Q2 2012 · Sep 30, 2011 $1.79M
Gross Profit Q2 2012 · Sep 30, 2011 $4.36M
Cost Of Revenue Q2 2012 · Sep 30, 2011 $2.1M
Cost Of Revenue Q2 2012 · Sep 30, 2011 $5.09M